Acorda Therapeutics is a biotechnology company based in Ardsley, New York, USA. The company develops drugs to improve therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Acorda manufactures and markets the drugs Zanaflex, Ampyra and Qutenza in the United States.
History
Corporate governance
As of December 31, 2013, the members of the board of directors of Acorda Therapeutics were: Ron Cohen, Barry Greene, Peder K. Jensen, John P. Kelley, Sandra Panem, Lorin J. Randall, Steven M. Rauscher, and Ian F. Smith.
Products
Products on the market
- Zanaflex
- Ampyra
- Qutenza
Products under development
References
External links
- Official website
- Acorda Therapeutics Inc., The New York Times
- Acorda Therapeutics Inc., Hoover's
0 komentar :
Posting Komentar